Zimmer Pulls Metal-on-Metal Durom Acetabular Hip Implants from Australian Market

Orthopedic devices giant Zimmer cancels its Durom acetabular hip implant component from the Australian market amid higher revision rates.

In another blow to the metal-on-metal hip implant market, orthopedic giant Zimmer Holdings [1] (NYSE:ZMH [2]) canceled its Durom Acetabular Component from the Australian Register of Therapeutic Goods, the regulatory agency announced this week.

The implant, which had virtually faded from use already, was pulled after data showed that it was responsible for higher revision rates compared with similar devices.